286 related articles for article (PubMed ID: 6337172)
1. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
Griffing GT; Dale SL; Holbrook MM; Melby JC
J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
[TBL] [Abstract][Full Text] [Related]
2. The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
Griffing GT; Dale SL; Holbrook MM; Melby JC
J Clin Endocrinol Metab; 1983 Jan; 56(1):99-103. PubMed ID: 6292258
[TBL] [Abstract][Full Text] [Related]
3. Prohormones in adrenal venous effluent in patients with primary hyperaldosteronism.
Rao A; Melby JC; Wilson TE
J Clin Endocrinol Metab; 1995 May; 80(5):1677-80. PubMed ID: 7745017
[TBL] [Abstract][Full Text] [Related]
4. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
Griffing GT; Dale SL; Holbrook MM; Melby JC
Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
[TBL] [Abstract][Full Text] [Related]
5. Urinary free 19-nor-deoxycorticosterone and deoxycorticosterone in human hypertension.
Gomez-Sanchez CE; Holland OB; Upcavage R
J Clin Endocrinol Metab; 1985 Feb; 60(2):234-8. PubMed ID: 3880766
[TBL] [Abstract][Full Text] [Related]
6. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
Nakada T
Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
[TBL] [Abstract][Full Text] [Related]
7. [Aldosterone precursors and hypertension with hypokalemia and adrenal module non caused by primary hyperaldosteronism].
Chamontin B; Blanchouin-Emeric N; Amar J; Khatibi F; Vernier I; Bennet A; Aupetit-Faisant B; Salvador M
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1055-8. PubMed ID: 8949378
[TBL] [Abstract][Full Text] [Related]
8. Elevated urinary 19-Nor-deoxycorticosterone glucuronide in Cushing's syndrome.
Ehlers ME; Griffing GT; Wilson TE; Melby JC
J Clin Endocrinol Metab; 1987 May; 64(5):926-30. PubMed ID: 3558730
[TBL] [Abstract][Full Text] [Related]
9. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
[TBL] [Abstract][Full Text] [Related]
10. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
Kater CE; Biglieri EG; Schambelan M; Arteaga E
Hypertension; 1983; 5(6 Pt 3):V115-21. PubMed ID: 6360878
[TBL] [Abstract][Full Text] [Related]
11. Unconjugated and conjugated urinary 19-nor-deoxycorticosterone glucosiduronate. Elevated levels in essential hypertension.
Griffing GT; Wilson TE; Melby JC
Hypertension; 1985; 7(3 Pt 2):I12-7. PubMed ID: 3873413
[TBL] [Abstract][Full Text] [Related]
12. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC
Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
[TBL] [Abstract][Full Text] [Related]
13. Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia.
Wu VC; Chueh SC; Chang HW; Lin WC; Liu KL; Li HY; Lin YH; Wu KD; Hsieh BS
QJM; 2008 Jan; 101(1):13-22. PubMed ID: 18203722
[TBL] [Abstract][Full Text] [Related]
14. Low renin essential hypertension: failure to demonstrate excess 11-deoxycorticosterone production.
Tan SY; Mulrow PJ
J Clin Endocrinol Metab; 1979 Nov; 49(5):790-3. PubMed ID: 489719
[TBL] [Abstract][Full Text] [Related]
15. Plasma and urinary 19-nor-deoxycorticosterone in 17 alpha-hydroxylase deficiency syndrome.
Griffing GT; Wilson TE; Holbrook MM; Dale SL; Jackson TK; Ullrich I; Melby JC
J Clin Endocrinol Metab; 1984 Nov; 59(5):1011-5. PubMed ID: 6332824
[TBL] [Abstract][Full Text] [Related]
16. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
17. Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma.
Olivieri O; Cecconi D; Castagna A; Chiecchi L; Guarini P; Gunasekaran M; Morandini F; Brazzarola P; Zolla L; D'Alessandro A; Veglio F; Mulatero P; Pizzolo F
Mol Biosyst; 2014 Jun; 10(6):1281-9. PubMed ID: 24503858
[TBL] [Abstract][Full Text] [Related]
18. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
[TBL] [Abstract][Full Text] [Related]
19. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.
Kline GA; Pasieka JL; Harvey A; So B; Dias VC
Ann Surg Oncol; 2013 Jul; 20(7):2274-8. PubMed ID: 23504117
[TBL] [Abstract][Full Text] [Related]
20. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
Melby JC; Dale SL
Mayo Clin Proc; 1977 May; 52(5):317-22. PubMed ID: 870774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
